Mr Hill joins the UK and Ireland law firm’s health and life sciences practice from Blake Morgan. He specialises in supporting healthcare organisations to successfully adopt new medicines, technologies, and service models that enhance care and improve outcomes.

His clients include health service bodies across the UK, as well as independent healthcare providers and HealthTech companies based in the UK, Europe and North America. Mr Hill has had involvement in the development of health sector legislation and national policy, including integrated care, access to medicines and the evaluation of health technologies.

Mr Hill said: “Browne Jacobson has an outstanding reputation for advising clients at the most complex and consequential end of health service commissioning and delivery, which is exactly where I have spent my career.

“The digital transformation of health services, and the adoption of new medicines and technologies, raises genuinely novel legal questions that cut across public law, regulation, privacy and governance.

“The firm’s breadth across those disciplines, and its deep relationships across both the NHS and the independent health and care sector, means it is uniquely placed to help clients navigate that landscape.”

Mr Hill began his legal career in-house at Health and Social Care Northern Ireland. He subsequently qualified as an English solicitor and practised for several years in the North West before relocating to the South East.

He has predominantly advised the health sector, both NHS and independent, alongside advising local authorities, central government departments, regulatory bodies such as the Information Commissioner’s Office, and governments of UK Crown Dependencies. Mr Hill’s practice increasingly focuses on the evaluation and deployment of new medicines and health technologies, including AI-enabled medical devices.

Gerard Hanratty, partner and head of health and life sciences at Browne Jacobson, added: “David is an exceptional addition to our team and brings a rare combination of policy insight, regulatory expertise, and deep practical experience of the NHS. His track record – from primary legislation and medicines regulation through to the deployment of AI-enabled health technologies – is precisely what our clients working at the forefront of tackling society’s biggest issues need as the digital transformation of health services accelerates.”